Abstract: The invention provides a composition containing human epidermal growth factor (EGF) and radiolabeled human transferrin. The composition is useful for the treatment of tumors and other diseases.

Abstract: The invention provides methods useful for the diagnosis, imaging and treatment of tumors and other diseases. The methods of the invention involve the administration of a composition containing human vascular endothelial growth factor (VEGF), radiolabeled human transferrin and human epidermal growth factor (EGF) to a host suspected of having or having a tumor.

Abstract: The invention provides compositions containing at least one ligand such as human epidermal growth factor (EGF) or human vascular endothelial growth factor (VEGF), a nucleic acid and a human transferrin ligand. The compositions are useful for the multi-targeted delivery of nucleic acids to cells and tissues.

Abstract: The invention provides methods useful for the multi-targeted delivery of nucleic acids to cells and tissues. The methods of the invention involve the administration of compositions containing at least one ligand such as human epidermal growth factor (EGF) or human vascular endothelial growth factor (VEGF), a nucleic acid and a human transferrin ligand to a host having cells to which nucleic acids can be delivered.

Abstract: The invention provides methods useful for the delivery of anti-tumor agents to a host having a tumor. The methods of the invention involve the administration of compositions containing a ligand such as human epidermal growth factor (EGF) or human vascular endothelial growth factor (VEGF), an anti-tumor agent and a human transferrin ligand to a host having a tumor.

Abstract: The invention provides methods useful for the treatment of tumors and other diseases. The methods of the invention involve the administration of a composition containing human epidermal growth factor (EGF) and radiolabeled human transferrin to a host having a tumor.

Abstract: The invention provides methods useful for the treatment of tumors and other diseases. The methods of the invention involve the administration of a composition containing two conjugates; the first conjugate containing human vascular endothelial growth factor (VEGF) and radiolabeled human transferrin and the second conjugate containing human epidermal growth factor (EGF) and radiolabeled human transferrin to a host having a tumor.

Abstract: The invention provides methods useful for the treatment of tumors and other diseases. The methods of the invention involve the administration of a composition containing human vascular endothelial growth factor (VEGF) and radiolabeled human transferrin to a host having a tumor.

Abstract: The invention provides compositions containing a ligand such as human epidermal growth factor (EGF) or human vascular endothelial growth factor (VEGF), an anti-tumor agent and a human transferrin ligand. The compositions are useful for the delivery of anti-tumor agents to a host having a tumor.

Abstract: The invention provides a composition containing two conjugates; the first conjugate containing human vascular endothelial growth factor (VEGF) and radiolabeled human transferrin and the second conjugate containing human epidermal growth factor (EGF) and radiolabeled human transferrin. The composition is useful for the treatment of tumors and other diseases.

Abstract: The invention provides a composition containing human vascular endothelial growth factor (VEGF) and radiolabeled human transferrin. The composition is useful for the treatment of tumors and other diseases.

Abstract: The invention provides a composition containing human vascular endothelial growth factor (VEGF), radiolabeled human transferrin and human epidermal growth factor (EGF). The composition is useful for the diagnosis, imaging and treatment of tumors and other diseases.